AzTrials
AzTrials

Adolescent PregnancyMCMHNCT04700059

Family Intervention to Improve Maternal and Child Mental Health

A study testing Virtual perinatal home visiting in people with Adolescent Pregnancy, run by Massachusetts General Hospital at 1 site in Peru.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

This pilot study will assess the acceptability, feasibility and efficacy of a family-based intervention to improve maternal and child mental health by increasing maternal sensitivity and decreasing offspring abuse among adolescent mothers in Perú, a middle-income country with high rates of childhood physical and… Read more about this study

Who is it for?
Ages 14 years and olderHealthy volunteers can take part
Conditions the study is for
Adolescent Pregnancy
What is being tested?
Virtual perinatal home visiting
Could I receive a placebo?
No, everyone receives an active treatment
How many people
300 participants
Where
1 sitePeru
Study dates
1 Dec 2020to 28 Feb 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 14 years and older
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • All subjects must be able to read and write Spanish.
  • RCT will be limited to pregnant adolescents who are between the ages of 14-19 years and 12-34 weeks gestational age. Other caregivers (age 14 years or older) will be eligible if they are planning to be involved in infant care.
  • Only pregnant adolescents receiving outpatient prenatal care at INMP or San Bartolomé will be approached as potential participants.
  • Only pregnant adolescents who have been cleared by their attending doctor/nurse to engage in the approach/recruitment and interview procedure will be approached as potential participants.
  • All infants born to adolescents enrolled during pregnancy will be eligible to be enrolled after birth.

Who cannot join

  • Anyone unable to read and write Spanish.
  • Any pregnant adolescent known to have a severe fetal anomaly will not be approached.
  • Infants who are advised not to participate by their attending doctor or pediatrician.
  • Children or adolescents who are wards of the state will not be enrolled.

Trial locations and contacts

1 site in 1 country.

Peru1 site
  • Instituto Nacional Materno Perinatal

    Lima

Other trials in Peru

About this study

Official title: Adaptation and Assessment of a Family Intervention Designed to Improve Maternal and Child Mental Health in a Resource-limited Setting

This pilot study will assess the acceptability, feasibility and efficacy of a family-based intervention to improve maternal and child mental health by increasing maternal sensitivity and decreasing offspring abuse among adolescent mothers in Perú, a middle-income country with high rates of childhood physical and sexual abuse, IPV, and adolescent pregnancy.

Read the detailed description

Participants will be recruited from the prenatal clinics at INMP and San Bartolomé. Due to COVID-19, the prenatal clinics are currently conducting only telehealth visits. The interviews will be conducted using structured questionnaires that cover questions about socio-demographic characteristics, lifestyle characteristics, symptoms of depression or PTSD, history of trauma, and medical, obstetric and psychiatric history. Participants will be able to enter their responses online, with a research team member available to answer questions by phone, or they can give their answers by phone while a team member enters them. See attached Initial Questionnaire for details.

After the interview, each participant will be asked to provide the name of someone whom she anticipates will be helping her to care for the child. We expect that in most cases this will be a female relative of the participant, typically her mother or grandmother, but it may also be a friend or the baby's father. The participant will be given information about the study to provide to the other caregiver, and the interviewer will contact the other caregiver within a week of enrolling the participant and arrange for a convenient time for the caregiver to learn about the study and go through the informed consent procedures. If more than one person is providing significant support to the mother, she may identify up to two other caregivers. She can also identify a second caregiver at a later point.

Each participating family will be randomized to either the intervention arm or the usual care arm. Usual care consists of routine prenatal care and pediatric follow up at 2 weeks, 2 months, 4 months and 6 months. If enrolled prior to 20 weeks gestation, participants in both groups will receive a short phone call to check in every 4 weeks, until they reach 24 weeks gestation, to minimize the gap before the first visit at 28 weeks.

After delivery, obstetric records will be reviewed for information about gestational age, birth weight, and any complications. See attached Birth Data form for planned data collection.

Due to COVID-19, the intervention will begin with virtual visits conducting via videoconferencing. If, during the study period, it becomes safe to do home visits, we may switch to in-person home visits, or we may conduct the entire study with virtual visits. The intervention consists of 2 prenatal and 8 postpartum visits, with visit frequency gradually decreasing as mothers gain experience and confidence. Visits will last for up to 90 minutes to allow time for multiple caregivers to participate. Other caregivers will be encouraged to participate for the first 10 minutes and the last 20 minutes of the intervention sessions. As much as possible, visits will accommodate the family schedule, occurring at a time when all or most of the caregivers are at home. The perspectives of all caregivers will be elicited by the home visitor in order to facilitate a conversation among them about their preferences, concerns, and goals.

After completion of either the intervention or the control condition, the adolescent mothers will repeat the questionnaires about demographics, as well as anxiety, depression, PTSD and trauma history. If COVID-19 precautions are still necessary during this phase of the study, the post-intervention questionnaires will be completed in the same manner as the initial questionnaires, with data entered online with the support of the research team by phone. See attached Post-intervention Questionnaire for details. Interactions between the mother and infant, other caregiver and infant, and all three together will be video recorded and coded to assess caregiver sensitivity. If COVID-19 precautions are still necessary, these assessments will be conducted using video conferencing, and the video calls will be recorded and coded in the manner described. These recordings will be assessed and coded across five dimensions: "physical involvement," "verbal involvement," "responsiveness," "positive statements," and "control over child's activities," each rated 0-5 for the "quality" and "appropriateness" of caregiver behavior (Cooper et al., 2009; Farran, Kasari, Comfort, \& Jay, 1986). Finally, the Still Face Paradigm will be conducted in which the mother-infant dyads will perform a video recorded 3-minute face-to-face interaction consisting of 1 minute normal, 1 minute still-face, and 1 minute reunion after still-face. Maternal behavior will be scored for sensitivity during normal and reunion phases (scored 0-5) (Murray, Fiori-Cowley, Hooper, \& Cooper, 1996); infants will be scored for regulatory behavior (Braungart-Rieker, Garwood, Powers, \& Wang, 2001; Murray \& Trevarthen, 1985; Tronick \& Weinberg, 1994) and dysregulated behavior, including gaze aversion, facial expression, crying, and agitated movement during each 1-second interval (Gunning, Halligan, \& Murray, 2013).

We will record only what is necessary for the research record and take all steps necessary to blur/obscure the images of those who have not consented to the research and/or to being recorded or photographed. All interview guides and other study materials not currently available will be submitted to the IRB for approval prior to use.

Being tested
Virtual perinatal home visiting
Keywords
Perinatal intervention, Intergenerational trauma
Medical subject headings
Historical Trauma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Virtual perinatal home visitingBehavioural

    10 perinatal home visits

Study groups in NCT04700059
Study groupRoleWhat they receive
InterventionExperimental10 perinatal home visits
Receives: Behavioral: Virtual perinatal home visiting
Usual careNo interventionRoutine medical care for mother and infant. Access to online resources.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Emotional availability scales

    Video recorded coded assessment of caregiver and infant interaction

    Measured: 6 months after birth

Secondary outcomes (3)
  1. PHQ-9

    Maternal depression

    Measured: At enrollment and 6 months after birth

  2. GAD-7

    Maternal anxiety

    Measured: At enrollment and 6 months after birth

  3. PCL-C

    Maternal PTSD

    Measured: At enrollment and 6 months after birth

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jan 2021
  2. Study start1 Dec 2020
  3. Primary completion31 Aug 2022 (estimated)
  4. Study completion28 Feb 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
300 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04700059
Sponsor's protocol ID
IRB18-0533
Acronym
MCMH
Status last verified
Jun 2022
First submitted
5 Jan 2021
Last updated
9 Jun 2022
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Virtual perinatal home visiting in people with Adolescent Pregnancy, run by Massachusetts General Hospital at 1 site in Peru.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 9 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Peru. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Emotional availability scales (time frame: 6 months after birth). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Jun 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in